Cost-effectiveness of short-protocol emergency brain MRI after negative non-contrast CT for minor stroke detection.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 12 03 2021
accepted: 25 06 2021
revised: 23 05 2021
pubmed: 30 8 2021
medline: 1 2 2022
entrez: 29 8 2021
Statut: ppublish

Résumé

To investigate the cost-effectiveness of supplemental short-protocol brain MRI after negative non-contrast CT for the detection of minor strokes in emergency patients with mild and unspecific neurological symptoms. The economic evaluation was centered around a prospective single-center diagnostic accuracy study validating the use of short-protocol brain MRI in the emergency setting. A decision-analytic Markov model distinguished the strategies "no additional imaging" and "additional short-protocol MRI" for evaluation. Minor stroke was assumed to be missed in the initial evaluation in 40% of patients without short-protocol MRI. Specialized post-stroke care with immediate secondary prophylaxis was assumed for patients with detected minor stroke. Utilities and quality-of-life measures were estimated as quality-adjusted life years (QALYs). Input parameters were obtained from the literature. The Markov model simulated a follow-up period of up to 30 years. Willingness to pay was set to $100,000 per QALY. Cost-effectiveness was calculated and deterministic and probabilistic sensitivity analysis was performed. Additional short-protocol MRI was the dominant strategy with overall costs of $26,304 (CT only: $27,109). Cumulative calculated effectiveness in the CT-only group was 14.25 QALYs (short-protocol MRI group: 14.31 QALYs). In the deterministic sensitivity analysis, additional short-protocol MRI remained the dominant strategy in all investigated ranges. Probabilistic sensitivity analysis results from the base case analysis were confirmed, and additional short-protocol MRI resulted in lower costs and higher effectiveness. Additional short-protocol MRI in emergency patients with mild and unspecific neurological symptoms enables timely secondary prophylaxis through detection of minor strokes, resulting in lower costs and higher cumulative QALYs. • Short-protocol brain MRI after negative head CT in selected emergency patients with mild and unspecific neurological symptoms allows for timely detection of minor strokes. • This strategy supports clinical decision-making with regard to immediate initiation of secondary prophylactic treatment, potentially preventing subsequent major strokes with associated high costs and reduced QALY. • According to the Markov model, additional short-protocol MRI remained the dominant strategy over wide variations of input parameters, even when assuming disproportionally high costs of the supplemental MRI scan.

Identifiants

pubmed: 34455484
doi: 10.1007/s00330-021-08222-z
pii: 10.1007/s00330-021-08222-z
pmc: PMC8794930
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1117-1126

Informations de copyright

© 2021. The Author(s).

Références

Stroke. 2010 Apr;41(4):661-6
pubmed: 20185781
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
N Engl J Med. 2018 Aug 16;379(7):611-622
pubmed: 29766770
J Clin Epidemiol. 1999 Mar;52(3):259-71
pubmed: 10210244
Radiology. 2018 Aug;288(2):518-526
pubmed: 29893641
Neuroradiology. 2013 Jul;55(7):827-35
pubmed: 23568701
Eur J Neurol. 2011 Mar;18(3):430-5
pubmed: 20642795
Value Health. 2005 Sep-Oct;8(5):572-80
pubmed: 16176495
Ann Neurol. 2005 Jun;57(6):848-54
pubmed: 15929051
N Engl J Med. 2016 Apr 21;374(16):1533-42
pubmed: 27096581
J Comp Eff Res. 2015 Aug;4(4):377-84
pubmed: 26274799
Expert Rev Pharmacoecon Outcomes Res. 2007 Aug;7(4):357-63
pubmed: 20528418
PLoS One. 2014 Aug 21;9(8):e105413
pubmed: 25144396
Natl Vital Stat Rep. 2018 Nov;67(7):1-64
pubmed: 30707669
PLoS One. 2016 Feb 03;11(2):e0148106
pubmed: 26840397
N Engl J Med. 2014 Aug 28;371(9):796-7
pubmed: 25162885
N Engl J Med. 2018 Jun 07;378(23):2182-2190
pubmed: 29766771
Neuroepidemiology. 2013;40(1):50-5
pubmed: 23075482
Glob Health Action. 2018;11(1):1447828
pubmed: 29564962
Stroke. 2009 May;40(5):1710-20
pubmed: 19286581
Neurology. 2017 Jan 17;88(3):237-244
pubmed: 27927939
Lancet. 2007 Oct 20;370(9596):1432-42
pubmed: 17928046
JAMA. 2016 Sep 13;316(10):1093-103
pubmed: 27623463
Stroke. 2014 Jul;45(7):2160-236
pubmed: 24788967
Neurology. 2001 Jul 24;57(2):305-14
pubmed: 11468317
Stroke. 2015 Aug;46(8):2238-43
pubmed: 26138130
Lancet. 2005 Jul 2-8;366(9479):29-36
pubmed: 15993230
Neurology. 2015 Jun 2;84(22):2208-15
pubmed: 25934858
Stroke. 2016 Nov;47(11):2797-2804
pubmed: 27758942
Lancet. 2016 Jul 23;388(10042):365-375
pubmed: 27209146
Stroke. 1994 Jan;25(1):40-3
pubmed: 8266381
Eur J Health Econ. 2019 Feb;20(1):107-134
pubmed: 29909569
Value Health. 2016 Dec;19(8):929-935
pubmed: 27987642
Neurology. 2005 Mar 8;64(5):817-20
pubmed: 15753415
Invest Radiol. 2020 Mar;55(3):181-189
pubmed: 31917761
Cerebrovasc Dis Extra. 2013 Oct 08;3(1):130-6
pubmed: 24403904
Circulation. 2017 Mar 21;135(12):1145-1159
pubmed: 28159800
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
Int J Stroke. 2014 Jan;9(1):6-18
pubmed: 24350870
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281

Auteurs

Daniel Puhr-Westerheide (D)

Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. daniel.puhr-westerheide@med.uni-muenchen.de.

Matthias F Froelich (MF)

Department of Radiology and Nuclear Medicine, University Medical Centre Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Olga Solyanik (O)

Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Eva Gresser (E)

Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Paul Reidler (P)

Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Matthias P Fabritius (MP)

Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Matthias Klein (M)

Department of Neurology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Konstantin Dimitriadis (K)

Department of Neurology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.

Jens Ricke (J)

Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Clemens C Cyran (CC)

Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Wolfgang G Kunz (WG)

Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Philipp M Kazmierczak (PM)

Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH